Tonix Pharmaceuticals Holding (TNXP) Preferred Dividend Payments (2020 - 2022)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Preferred Dividend Payments came in at $2.4 million in Q4 2022, down 43.5% quarter-over-quarter from $4.3 million in Q2 2022.
Tonix Pharmaceuticals Holding (TNXP) Preferred Dividend Payments (2020 - 2022) Analysis & Trends
Tonix Pharmaceuticals Holding's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $2.4 million for Q4 2022.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $2.4 million in Q4 2022; TTM through Dec 2022 was $6.7 million, a N/A change from a year earlier, with the FY2022 full-year figure at $6.7 million, changed N/A from the prior year.
- Preferred Dividend Payments eased to $2.4 million in Q4 2022 per TNXP's latest filing, from $4.3 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $4.3 million in Q2 2022 and bottomed at $1.3 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,023.69 Bn | 1,023.69 Bn | - | - |
| 4 | BeOne Medicines | 468.59 Bn | 463.80 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 123.01 Bn | 115.76 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.29 Bn | 61.53 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.33 Bn | 63.33 Bn | - | - |
| 8 | Argenx Se | 55.70 Bn | 50.52 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | - |
| 10 | Tonix Pharmaceuticals Holding | 140.50 Mn | 140.50 Mn | 5.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.40 Mn |
| Jun 30, 2022 | 4.26 Mn |
| Mar 31, 2020 | 1.26 Mn |